EVOLVE Short DAPT Study

What is the purpose of this trial?

The EVOLVE Short DAPT Study is a prospective, multicenter, single-arm study designed to assess the safety of 3-month DAPT in subjects at high risk for bleeding undergoing PCI with a SYNERGY Stent System.


Participation Guidelines

Ages: 18 years and older

Gender: Both


Boston Scientific Corporation

Dates: 08/10/2016 - 04/30/2019

Last Updated: 08/11/2016

Study HIC#: 1603017502

Get Involved

For more information about this study, contact:
Nancy J. Hinchion
203-453-7056
nancy.hinchion@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image